Copyright
©The Author(s) 2022.
World J Gastroenterol. Dec 21, 2022; 28(47): 6752-6768
Published online Dec 21, 2022. doi: 10.3748/wjg.v28.i47.6752
Published online Dec 21, 2022. doi: 10.3748/wjg.v28.i47.6752
Figure 4 Interleukin-34 deficiency inhibits proliferation and promotes apoptosis of colonic epithelium in dextran sodium sulfate-induced colitis.
A: Representative photomicrographs of Ki-67 immunohistochemical staining for colon sections of IL-34-/- and WT mice treated with dextran sodium sulfate (DSS); B: Percentage of proliferation marker Ki-67 per crypt; C and D: Representative microscopic pictures of TUNEL staining (C) and quantification of TUNEL-positive cells per field (D) in IL-34-/- and WT mice treated with DSS as before; E: mRNA expression of three receptors for IL-34 (CSF1R, ptprz1 and syndecan-1) was detected in IL-34-/- and WT mice treated with DSS (n = 6 or 7 per group); F and G: Representative photomicrographs of CSF1R immunohistochemical staining (F) and percentage of CSF1R-positive cells (G) in colon sections of IL-34-/- and WT mice treated with 3% DSS. CSF1R: Colony-stimulating factor-1 receptor; DSS: Dextran sodium sulfate; IL-34: Interleukin-34; WT: Wild-type. Scale bars = 100 μm. Data depict mean ± SD. aP < 0.05, bP < 0.01, cP < 0.005.
- Citation: Liu ZX, Chen WJ, Wang Y, Chen BQ, Liu YC, Cheng TC, Luo LL, Chen L, Ju LL, Liu Y, Li M, Feng N, Shao JG, Bian ZL. Interleukin-34 deficiency aggravates development of colitis and colitis-associated cancer in mice. World J Gastroenterol 2022; 28(47): 6752-6768
- URL: https://www.wjgnet.com/1007-9327/full/v28/i47/6752.htm
- DOI: https://dx.doi.org/10.3748/wjg.v28.i47.6752